Comirnaty®

WITHDRAWN · PHASE3 · SARS-CoV-2 Infection

The development of this product is terminated.

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.